Drugs / central memory T cells
Trials 1
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| Phase 1/2 | NCT03085966 | Feb 2017 → Oct 2019 | castration-resistant prostate carcinoma | Shanghai AbelZeta Ltd. | Unknown | No outcome recorded |
Evidence & citations 2 cited values
Every value below carries the sentence it was read from. 1 source stands behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | central memory T cells | “central memory T cells (Tcm cells) that are able to mount an attack against cancer cells” NCT03085966 ↗ |
| Known as | Tcm cells | “central memory T cells (Tcm cells) that are able to mount an attack against cancer cells” NCT03085966 ↗ |